Plant-Based Vaccines Market Report 2026
Global Outlook – By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types), By Source (Tobacco Plant, Maize, Potato, Other Sources), By Application (Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications) – Market Size, Trends, Strategies, and Forecast to 2030
Plant-Based Vaccines Market Overview
• Plant-Based Vaccines market size has reached to $1.81 billion in 2025 • Expected to grow to $3.06 billion in 2030 at a compound annual growth rate (CAGR) of 11.3% • Growth Driver: Increased Prevalence Of Infectious Diseases Fuels Growth In The Plant-Based Vaccine Market • Market Trend: Strategic Manufacturing Collaborations Strengthen Virus-Like Particle (VLP) Production Capacity In The Plant-Based Vaccines Market • North America was the largest region in 2025.What Is Covered Under Plant-Based Vaccines Market?
Plant-based vaccines refer to recombinant vaccines that incorporate antigens against certain infections into the chosen plant. Most human and animal diseases can be effectively treated with plant-based vaccinations. The main vaccine types of plant-based vaccines are bacterial vaccines, viral vaccines, parasite vaccines, and others. A bacterial vaccine refers to a preparation of dead or weakened bacteria employed as an active immunizing agent. The various sources include tobacco plants, maize, potato, and others, and are used in various applications such as influenza, zika virus, ebola virus, poultry disease, and others.
What Is The Plant-Based Vaccines Market Size and Share 2026?
The plant-based vaccines market size has grown rapidly in recent years. It will grow from $1.81 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to limited cold chain infrastructure in developing regions, high cost of conventional vaccine production, increasing prevalence of zoonotic diseases, early academic research in plant molecular farming, government support for alternative biologics.What Is The Plant-Based Vaccines Market Growth Forecast?
The plant-based vaccines market size is expected to see rapid growth in the next few years. It will grow to $3.06 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to rising demand for scalable vaccine platforms, growth in pandemic preparedness programs, increasing investment in plant biotechnology startups, demand for cost-effective veterinary vaccines, regulatory progress for novel vaccine platforms. Major trends in the forecast period include expansion of recombinant antigen expression in plants, rising adoption of plant-based platforms for veterinary vaccines, increased focus on oral and edible vaccine development, growing public and private funding for alternative vaccine platforms, advancements in downstream processing and purification technologies.
Global Plant-Based Vaccines Market Segmentation
1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types 2) By Source: Tobacco Plant, Maize, Potato, Other Sources 3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications Subsegments: 1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines 2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines 3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines 4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based VaccinesWhat Is The Driver Of The Plant-Based Vaccines Market?
The high prevalence of infectious diseases is expected to propel the growth of the plant-based vaccines market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, or parasites, which can spread directly or indirectly and pose significant health risks worldwide. The increase in infectious disease cases is driven by factors such as greater global mobility, urban crowding, and weakened immunity in certain populations. Plant-based vaccines offer innovative platforms that can be rapidly scaled and adapted to address these rising health challenges. For instance, in March 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, the number of tuberculosis (TB) cases rose from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 cases. Therefore, the high prevalence of infectious diseases is driving the growth of the plant-based vaccines industry.Key Players In The Global Plant-Based Vaccines Market
Major companies operating in the plant-based vaccines market are British American Tobacco PLC, Medicago Inc., Creative Biolabs Inc., Fraunhofer USA Inc., Biodextris Inc., Avesthagen Limited, Calyxt Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG, Zyus Life Sciences Inc., Agenus Inc.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Plant-Based Vaccines Market Trends and Insights
Major companies operating in the plant-based vaccines market are engaging in strategic manufacturing collaborations to expand clinical-stage production capabilities and accelerate the advancement of next-generation VLP-based vaccines. The strategic manufacturing partnerships aim to enhance downstream processing efficiency, ensure GMP-compliant manufacturing, and support seamless transition from early-stage research to clinical development. For instance, in December 2024, Aramis Biotechnologies Inc., a Canada-based company specializing in plant-based biomanufacturing of innovative vaccines, partnered with Biodextris Inc., a Canada-based CDMO specializing in cGMP complex biologic products, to support Phase 1 and Phase 2 clinical trials. Under this collaboration, the partner will perform purification, formulation, and fill-finish activities for plant-expressed VLP vaccine candidates, enabling faster scale-up, improved production quality, and strengthened readiness for advanced clinical evaluation.What Are Latest Mergers And Acquisitions In The Plant-Based Vaccines Market?
In December 2023, Aramis Biotechnologies, a Canada-based biotechnology company, acquired key assets from Medicago for an undisclosed amount. Through this acquisition, Aramis aims to strengthen its position in the plant-based vaccine market by leveraging Medicago’s virus-like particle (VLP) platform to develop next-generation influenza vaccines and therapeutics. The acquisition also preserves a high-speed domestic production capability, supporting sustainable biomanufacturing and improved pandemic preparedness. Medicago is a Canada-based biotech company that uses plant-based technology to develop vaccines.
Regional Insights
North America was the largest region in the plant-based vaccines market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Plant-Based Vaccines Market?
The plant-based vaccines market consists of sales of cholera vaccines and norovirus vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Plant-Based Vaccines Market Report 2026?
The plant-based vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the plant-based vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Plant-Based Vaccines Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.99 billion |
| Revenue Forecast In 2030 | $3.06 billion |
| Growth Rate | CAGR of 10.2% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Vaccine Type, Source, Application |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | British American Tobacco PLC, Medicago Inc., Creative Biolabs Inc., Fraunhofer USA Inc., Biodextris Inc., Avesthagen Limited, Calyxt Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG, Zyus Life Sciences Inc., Agenus Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |